Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Plos Genetics
|
March 28, 2015
Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis
Aymeric Chartier, Pierre Klein, Stéphanie Pierson, et al.
Human Molecular Genetics
|
January 17, 2019
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy
Alberto Malerba, Fanny Roth, Pradeep Harish, et al.
Skeletal Muscle
|
July 30, 2011
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
Seyed Yahya Anvar, Peter Ac 't Hoen, Andrea Venema, et al.
Journal of Virology
|
August 16, 2019
Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV
Neil Almond, Neil Berry, Richard Stebbings, et al.
Nucleic Acids Research
|
August 11, 2016
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing
Pierre Klein, Martine Oloko, Fanny Roth, et al.
EMBO Molecular Medicine
|
December 16, 2017
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy
Sara Benedetti, Narumi Uno, Hidetoshi Hoshiya, et al.
Nature Communications
|
May 29, 2015
Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
Frédérique Rau, Jeanne Lainé, Laetitita Ramanoudjame, et al.
Plos One
|
October 3, 2018
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
Monika Hiller, Maria Sofia Falzarano, Iker Garcia-Jimenez, et al.
Lancet (London, England)
|
July 26, 2011
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, et al.
Human Molecular Genetics
|
March 9, 2010
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres
Capucine Trollet, Seyed Yahya Anvar, Andrea Venema, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Plos Genetics
|
March 28, 2015
Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis
Aymeric Chartier, Pierre Klein, Stéphanie Pierson, et al.
Human Molecular Genetics
|
January 17, 2019
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy
Alberto Malerba, Fanny Roth, Pradeep Harish, et al.
Skeletal Muscle
|
July 30, 2011
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
Seyed Yahya Anvar, Peter Ac 't Hoen, Andrea Venema, et al.
Journal of Virology
|
August 16, 2019
Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV
Neil Almond, Neil Berry, Richard Stebbings, et al.
Nucleic Acids Research
|
August 11, 2016
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing
Pierre Klein, Martine Oloko, Fanny Roth, et al.
EMBO Molecular Medicine
|
December 16, 2017
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy
Sara Benedetti, Narumi Uno, Hidetoshi Hoshiya, et al.
Nature Communications
|
May 29, 2015
Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
Frédérique Rau, Jeanne Lainé, Laetitita Ramanoudjame, et al.
Plos One
|
October 3, 2018
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
Monika Hiller, Maria Sofia Falzarano, Iker Garcia-Jimenez, et al.
Lancet (London, England)
|
July 26, 2011
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, et al.
Human Molecular Genetics
|
March 9, 2010
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres
Capucine Trollet, Seyed Yahya Anvar, Andrea Venema, et al.
Page
of 11